Loading market data...
Latest Top News
Jubilant Pharmova Q2 Net Profit Rises to ₹1.2 Billion; Revenue Touches ₹19.66 Billion
Jubilant Pharmova Ltd reported a consolidated net profit of ₹1.2 billion for Q2 FY2026, with total revenue from operations reaching ₹19.66 billion. The growth was driven by strong performance in contract manufacturing, specialty pharmaceuticals, and cost optimization across global operations.
Stay Ahead – Explore Now! High Court Puts Mohali Aero City Expansion Land Acquisition Under Scanner






